Click on image to view larger version.

Figure 2 The absolute change in percent FMD following therapy compares with pretreatment baseline values for quinapril and enalapril based on ACE genotype. Significant improvement in FMD seen only in the quinapril group for the ID and II genotype (*p = 0.03).